Clinical Trials List
Protocol NumberSCPF20L01TW
2017-09-01 - 2019-12-31
Phase IV
Terminated2
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 趙培竣 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Po-Yu Chen Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
62 participants
-
Global
62 participants
